JPWO2020047368A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020047368A5
JPWO2020047368A5 JP2021511593A JP2021511593A JPWO2020047368A5 JP WO2020047368 A5 JPWO2020047368 A5 JP WO2020047368A5 JP 2021511593 A JP2021511593 A JP 2021511593A JP 2021511593 A JP2021511593 A JP 2021511593A JP WO2020047368 A5 JPWO2020047368 A5 JP WO2020047368A5
Authority
JP
Japan
Prior art keywords
subject
composition
virus
nucleic acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021511593A
Other languages
English (en)
Japanese (ja)
Other versions
JP7587275B2 (ja
JP2021535168A5 (https=
JP2021535168A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/048985 external-priority patent/WO2020047368A1/en
Publication of JP2021535168A publication Critical patent/JP2021535168A/ja
Publication of JPWO2020047368A5 publication Critical patent/JPWO2020047368A5/ja
Publication of JP2021535168A5 publication Critical patent/JP2021535168A5/ja
Priority to JP2024091954A priority Critical patent/JP7807105B2/ja
Application granted granted Critical
Publication of JP7587275B2 publication Critical patent/JP7587275B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021511593A 2018-08-30 2019-08-30 筋萎縮性側索硬化症の治療方法または予防方法 Active JP7587275B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024091954A JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862724780P 2018-08-30 2018-08-30
US62/724,780 2018-08-30
PCT/US2019/048985 WO2020047368A1 (en) 2018-08-30 2019-08-30 Methods of treating or preventing amyotrophic lateral sclerosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024091954A Division JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法

Publications (4)

Publication Number Publication Date
JP2021535168A JP2021535168A (ja) 2021-12-16
JPWO2020047368A5 true JPWO2020047368A5 (https=) 2022-06-13
JP2021535168A5 JP2021535168A5 (https=) 2022-06-13
JP7587275B2 JP7587275B2 (ja) 2024-11-20

Family

ID=69643060

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021511593A Active JP7587275B2 (ja) 2018-08-30 2019-08-30 筋萎縮性側索硬化症の治療方法または予防方法
JP2024091954A Active JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024091954A Active JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法

Country Status (9)

Country Link
US (2) US12508327B2 (https=)
EP (1) EP3844285A4 (https=)
JP (2) JP7587275B2 (https=)
KR (1) KR20210053305A (https=)
CN (1) CN112673107A (https=)
AU (2) AU2019328337B2 (https=)
CA (1) CA3107612A1 (https=)
IL (1) IL280965B2 (https=)
WO (1) WO2020047368A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3844285A4 (en) * 2018-08-30 2022-06-29 Rowan University Methods of treating or preventing amyotrophic lateral sclerosis
WO2025240562A1 (en) * 2024-05-15 2025-11-20 Woolsey Pharmaceuticals, Inc. Method of treating amyotrophic lateral sclerosis with trimetazidine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753379B1 (fr) * 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa Methode de traitement de la sclerose laterale amyotrophique
FR2923962B1 (fr) 2007-11-20 2009-11-20 Valeo Sys Controle Moteur Sas Circuit elevateur de tension
EP2826860B1 (en) * 2010-04-23 2018-08-22 University of Massachusetts CNS targeting AAV vectors and methods of use thereof
EP3778887B1 (en) * 2012-05-30 2025-07-09 Rowan University Nucleic acid encoding aspa for use in the treatment of parkinson's disease
US11413356B2 (en) 2016-04-15 2022-08-16 University Of Massachusetts Methods and compositions for treating metabolic imbalance
EP3844285A4 (en) 2018-08-30 2022-06-29 Rowan University Methods of treating or preventing amyotrophic lateral sclerosis

Similar Documents

Publication Publication Date Title
EP3030666B1 (en) Compositions and methods for treatment of muscular dystrophy
US10301367B2 (en) Compositions and methods for treatment of muscular dystrophy
US20230075314A1 (en) VECTORIZED ANTIBODIES (vAb) AND USES THEREOF
JP2024133479A5 (https=)
JP2020518259A5 (https=)
CN101288768A (zh) 用于治疗渐进神经退化症的医药组合物
JP2019501643A (ja) 認知及び行動障害のための薬剤としての哺乳動物クロトーの分泌されたスプライシングバリアント
RU2019103488A (ru) Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12
JP2020518269A (ja) 繊毛病のための遺伝子治療
JP2021535168A5 (https=)
US20220378942A1 (en) Compositions and methods for treating alzheimer's disease
JPWO2020047368A5 (https=)
US10639351B2 (en) Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor
CN112469430A (zh) 抑制大脑炎症的方法
JP6987749B2 (ja) Ｓｋチャネル阻害剤による学習障害および他の神経障害の治療
JPWO2022046988A5 (https=)
JP2022523038A (ja) 遺伝子置換及び抗炎症を介したデュシェンヌ型筋ジストロフィーに対する一段階遺伝子療法
US20230279434A1 (en) Methods and compositions for the treatment of als
US11535655B2 (en) Method of treating inflammatory bowel disease
EP4008356A1 (en) Methods and compositions for the treatment of als
JPWO2021155337A5 (https=)
TWI306770B (en) Pharmaceutical composition for rescuring learning or memory deficits
CN118909979A (zh) 一种重组腺相关病毒AAV-Lec及其制备方法和应用
McKim et al. The effect of emerging therapies on cardiopulmonary disease in Duchenne muscular dystrophy
HK40048942A (en) Methods of inhibiting cerebral inflammation